These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 39068425)

  • 1. Diagnostic performances of methylated septin9 gene, CEA, CA19-9 and platelet-to-lymphocyte ratio in colorectal cancer.
    Sun Q; Long L
    BMC Cancer; 2024 Jul; 24(1):906. PubMed ID: 39068425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical diagnostic value of methylated SEPT9 combined with NLR, PLR and LMR in colorectal cancer.
    Huang M; Deng S; Li M; Yang Z; Guo J; Deng Y; Chen D; Yan B
    BMC Gastroenterol; 2024 Jul; 24(1):240. PubMed ID: 39075402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylated Septin 9 as a Promising Biomarker in the Diagnosis and Recurrence Monitoring of Colorectal Cancer.
    Lu P; Zhu X; Song Y; Luo Y; Lin J; Zhang J; Cao Y; Huang Z
    Dis Markers; 2022; 2022():7087885. PubMed ID: 35818587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of circulating methylated Septin9 gene DNA in diagnosis and recurrence monitoring of colorectal cancer in Western China.
    Gao JJ; Wang YW; Li Y; Wang ZL; Feng A; Li N; Hui LY
    Clin Chim Acta; 2022 Dec; 537():118-126. PubMed ID: 36330944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stool
    Zhan Y; Wang S; Yuan Z; Zhao X; Ni K; Xin R; Zhou X; Liu Z; Yin X; Ping H; Liu Y; Wang W; Yan S; Han Q; Zhang X; Zhang Q; Liu Y; Zhang C
    Transl Cancer Res; 2023 Jan; 12(1):65-77. PubMed ID: 36760372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC.
    Peng HX; Yang L; He BS; Pan YQ; Ying HQ; Sun HL; Lin K; Hu XX; Xu T; Wang SK
    J Clin Lab Anal; 2017 Sep; 31(5):. PubMed ID: 27686880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic Value and Clinical Significance of Methylated SEPT9 for Colorectal Cancer: A Meta-Analysis.
    Hu J; Hu B; Gui YC; Tan ZB; Xu JW
    Med Sci Monit; 2019 Aug; 25():5813-5822. PubMed ID: 31378778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methylated Septin9 has moderate diagnostic value in colorectal cancer detection in Chinese population: a multicenter study.
    Lu DC; Zhang QF; Li L; Luo XK; Liang B; Lu YH; Hu BL; Jiang HX
    BMC Gastroenterol; 2022 May; 22(1):232. PubMed ID: 35546391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methylated Septin 9 and Carcinoembryonic Antigen for Serological Diagnosis and Monitoring of Patients with Colorectal Cancer After Surgery.
    Ma ZY; Law WL; Ng EKO; Chan CSY; Lau KS; Cheng YY; Shin VY; Kwong A; Leung WK
    Sci Rep; 2019 Jul; 9(1):10326. PubMed ID: 31316143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylated Septin9 identified patients with colorectal carcinoma and showed higher sensitivity than conventional biomarkers in detecting tumor.
    Leerhoff S; Raem A; Kolbe EW; Schulz L; Borchers K; Köhler T; Winde G; Kirchner C
    Cancer Treat Res Commun; 2023; 36():100748. PubMed ID: 37541105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The value of NLR, FIB, CEA and CA19-9 in colorectal cancer].
    Qian X; Wang H; Ren Z; Jin F; Pan SY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Apr; 55(4):499-505. PubMed ID: 33858062
    [No Abstract]   [Full Text] [Related]  

  • 12. Compare the Diagnostic and Prognostic Value of MLR, NLR and PLR in CRC Patients.
    Kang Y; Zhu X; Lin Z; Zeng M; Shi P; Cao Y; Chen F
    Clin Lab; 2021 Sep; 67(9):. PubMed ID: 34542964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison between Clinical Utility of CXCL-8 and Clinical Practice Tumor Markers for Colorectal Cancer Diagnosis.
    Huang Z; Li Z; Chen X; Zhu X; Zhang J; Song Y; Cao Y; Lu P
    Biomed Res Int; 2022; 2022():1213968. PubMed ID: 36567905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic Value of Carcinoembryonic Antigen Combined with Multi-Inflammatory Cell Ratios in Colorectal Cancer.
    Liu XC; Dai YL; Huang F; Zhong ZJ; Liu XF
    Dis Markers; 2022; 2022():4889616. PubMed ID: 36061352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic Value of Methylated
    Xie L; Jiang X; Li Q; Sun Z; Quan W; Duan Y; Li D; Chen T
    Front Oncol; 2018; 8():247. PubMed ID: 30013949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single and combined use of neutrophil-lymphocyte ratio, platelet-lymphocyte ratio and carcinoembryonic antigen in diagnosing gastric cancer.
    Wu Y; Jiang M; Qin Y; Lin F; Lai M
    Clin Chim Acta; 2018 Jun; 481():20-24. PubMed ID: 29476736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alu-based cell-free DNA: a potential complementary biomarker for diagnosis of colorectal cancer.
    Qi J; Qian C; Shi W; Wu X; Jing R; Zhang L; Wang Z; Ju S
    Clin Biochem; 2013 Jan; 46(1-2):64-9. PubMed ID: 22975639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The blood mSEPT9 is capable of assessing the surgical therapeutic effect and the prognosis of colorectal cancer.
    Song L; Guo S; Wang J; Peng X; Jia J; Gong Y; Yang B; Xiao W; Dong C; Liu H; Li Y
    Biomark Med; 2018 Sep; 12(9):961-973. PubMed ID: 30043648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stage-dependent changes of preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in colorectal cancer.
    Jia J; Zheng X; Chen Y; Wang L; Lin L; Ye X; Chen Y; Chen D; Dettke M
    Tumour Biol; 2015 Dec; 36(12):9319-25. PubMed ID: 26104767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of blood mSEPT9 in evaluating tumor burden and disease monitoring in colorectal cancer patients.
    Jiang H; Yu Q; Chen X; Zhang C; Shen J; Shen M; Yang Y; Wang B; Pan B; Guo W
    J Clin Lab Anal; 2021 Nov; 35(11):e24030. PubMed ID: 34591323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.